|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/46 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3412687 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18164175.4 |
| Date of filing the European patent application | 2011-10-27 | |
| (97) | Date of publication of the European application | 2018-12-12 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-18 |
| (46) | Date of publication of the claims translation | 2020-07-27 |
| (30) | Number | Date | Country code |
| 40710710 P | 2010-10-27 | US |
| (72) |
ZUGMAIER, Gerhard, DE
NAGORSEN, Dirk, US
SCHEELE, Juergen, DE
|
| (73) |
Amgen Research (Munich) GmbH,
Staffelseestrasse 2, 81477 München,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Didžiųjų B ląstelių difuzinės limfomos gydymo būdai |
| METHODS FOR TREATING DLBCL |
| Payment date | Validity (years) | Amount | |
| 2024-09-19 | 14 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2025-01-22 |